Long intergenic non-protein coding RNA 2688 (LINC02688)

Long intergenic non-protein coding RNA 2688 (LINC02688) is a long noncoding RNA (lncRNA), specifically a long intergenic noncoding RNA (lincRNA), which is transcribed from a genomic region that does not overlap protein-coding genes[3]. It is not a receptor, enzyme, transporter, or classical therapeutic target, but instead a regulatory RNA molecule primarily localized in the nucleus and, in some cases, the cytoplasm[7]. LINC02688 has regulatory functions in gene expression and may act as a tumor suppressor in gastric cancer, where it is significantly downregulated in tumoral tissues. It has been proposed as a novel biomarker for early diagnosis of gastric adenocarcinoma, as its reduced expression can distinguish tumor tissues from non-tumoral counterparts[1]. Although its function is not fully characterized, other lincRNAs are known to influence cancer progression by sponging microRNAs (ceRNA mechanism), serving as scaffolds for chromatin-modifying complexes, and competing with proteins[5][7]. No specific drugs, biomarkers for patient selection, or safety concerns are currently reported for LINC02688. Its role is focused on cancer biology and diagnostic applications rather than direct pharmacological targeting.

Other names

LINC02688Long intergenic noncoding RNA 2688